APA (7th ed.) Citation

Meng, M., Yu, B., Luo, J., Bai, Y., Li, L., Chen, S., . . . Ma, H. Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Meng, Mi, Bo Yu, Jie Luo, Yuju Bai, Lin Li, Shicheng Chen, Sisi He, and Hu Ma. Case Report: A Sustained Survival Benefit of Third-line Immunotherapy for Refractory Thymic Carcinoma. Frontiers Media S.A.

MLA (9th ed.) Citation

Meng, Mi, et al. Case Report: A Sustained Survival Benefit of Third-line Immunotherapy for Refractory Thymic Carcinoma. Frontiers Media S.A.